Page last updated: 2024-10-22

amsacrine and Abnormal Karyotype

amsacrine has been researched along with Abnormal Karyotype in 1 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Abnormal Karyotype: A variation from the normal set of chromosomes characteristic of a species.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmid, C1
Schleuning, M1
Tischer, J1
Holler, E1
Haude, KH1
Braess, J1
Haferlach, C1
Baurmann, H1
Oruzio, D1
Hahn, J1
Spiekermann, K1
Schlimok, G1
Schwerdtfeger, R1
Buechner, T1
Hiddemann, W1
Kolb, HJ1

Trials

1 trial available for amsacrine and Abnormal Karyotype

ArticleYear
Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study.
    Bone marrow transplantation, 2012, Volume: 47, Issue:1

    Topics: Abnormal Karyotype; Acute Disease; Adolescent; Adult; Amsacrine; Antilymphocyte Serum; Antineoplasti

2012